Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Newsletter Article
|
Press Release: scPharmaceuticals Inc. Reports -2Dow Jones Institutional News, 2023Copyright Dow Jones & Company Inc. Nov 8, 2023Digital Resources/Online E-Resources |
|
2 |
Material Type: Newsletter Article
|
Press Release: scPharmaceuticals Inc. Reports -2Dow Jones Institutional News, 2023Copyright Dow Jones & Company Inc. Aug 10, 2023Digital Resources/Online E-Resources |
|
3 |
Material Type: Newsletter Article
|
Press Release: scPharmaceuticals Inc. Reports -2Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. Mar 13, 2024Digital Resources/Online E-Resources |
|
4 |
Material Type: Newsletter Article
|
BioCardia (BCDA: 39.90c) inches higher, resistance at 12-day EMA; +0.9c [2.3%]News Bites US - NASDAQ, 2023Copyright News Bites Pty Ltd Nov 13, 2023Digital Resources/Online E-Resources |
|
5 |
Material Type: Newsletter Article
|
BioCardia (BCDA: 39.0c) sinks 4.9% weakening below moving average price; -2c [-4.9%]News Bites US - NASDAQ, 2023Copyright News Bites Pty Ltd Nov 10, 2023Digital Resources/Online E-Resources |
|
6 |
Material Type: Newsletter Article
|
BioCardia (BCDA: 41.0c) tumbles 5.7% on average volume, reports 730% sequential rise in Quarterly Revenue; -2.5c [-5.7%]News Bites US - NASDAQ, 2023Copyright News Bites Pty Ltd Nov 9, 2023Digital Resources/Online E-Resources |
|
7 |
Material Type: Newsletter Article
|
Cytokinetics (CYTK: $37.05) price 5.1% below VWAP on strong volumeNews Bites US - NASDAQ, 2021Copyright News Bites Pty Ltd Dec 8, 2021Digital Resources/Online E-Resources |
|
8 |
Material Type: Newsletter Article
|
Cytokinetics (CYTK: $37.47) lifts 3.6% strengthening above moving average priceNews Bites US - NASDAQ, 2021Copyright News Bites Pty Ltd Dec 7, 2021Digital Resources/Online E-Resources |
|
9 |
Material Type: Newsletter Article
|
Lexicon Pharmaceuticals Stock Jumps on 4Q Revenue, Sotagliflozin Heart Drug UpdateDow Jones Institutional News, 2023Copyright Dow Jones & Company Inc. Mar 3, 2023Digital Resources/Online E-Resources |
|
10 |
Material Type: Newsletter Article
|
Monthly: Nuwellis (NUWE: 54.0c) plunges 14%, 2 months' volume in a monthNews Bites US - NASDAQ, 2022Copyright News Bites Pty Ltd Oct 1, 2022Digital Resources/Online E-Resources |
|
11 |
Material Type: Newsletter Article
|
Press Release: Cytokinetics Reports First Quarter -2Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. May 8, 2024Digital Resources/Online E-Resources |
|
12 |
Material Type: Newsletter Article
|
Monthly: Applied Therapeutics (APLT: $4.42) plummets 35% on thin volume in April 2024News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 1, 2024Digital Resources/Online E-Resources |
|
13 |
Material Type: Newsletter Article
|
Monthly: scPharmaceuticals (SCPH: $4.47) falls a second month, trailing 74% of stocksNews Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 1, 2024Digital Resources/Online E-Resources |
|
14 |
Material Type: Newsletter Article
|
Press Release: CVRx Reports First Quarter 2024 Financial and Operating ResultsDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. Apr 30, 2024Digital Resources/Online E-Resources |
|
15 |
Material Type: Newsletter Article
|
Press Release: CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024Dow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. Apr 24, 2024Digital Resources/Online E-Resources |
|
16 |
Material Type: Newsletter Article
|
Press Release: CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating ResultsDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. Jan 25, 2024Digital Resources/Online E-Resources |
|
17 |
Material Type: Newsletter Article
|
CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating ResultsNASDAQ OMX's News Release Distribution Channel, 2024GlobeNewswire, Inc.Digital Resources/Online E-Resources |
|
18 |
Material Type: Newsletter Article
|
BioCardia (BCDA: 63.0c) tumbles 6.3% weakening below moving average price; -4.23c [-6.3%]News Bites US - NASDAQ, 2023Copyright News Bites Pty Ltd Dec 4, 2023Digital Resources/Online E-Resources |
|
19 |
Material Type: Newsletter Article
|
BioCardia (BCDA: 67.0c) surges 7.9% on rising relative strength; +4.88c [7.9%]News Bites US - NASDAQ, 2023Copyright News Bites Pty Ltd Dec 1, 2023Digital Resources/Online E-Resources |
|
20 |
Material Type: Newsletter Article
|
Press Release: CVRx Reports Fourth Quarter and Full Year 2021 Financial and Operating ResultsDow Jones Institutional News, 2022Copyright Dow Jones & Company Inc Feb 15, 2022Digital Resources/Online E-Resources |